New Blood Biomarker Predicts Alzheimer's in Cognitively Healthy Elderly

Researchers previously thought toxic amyloid accumulation in the brain was the sole contributing factor.

Pexels Matthias Zomer 339620
Matthias Zomer

Determining who will develop Alzheimer’s disease and who won’t is surprisingly nuanced. Previously, scientists believed that amyloid plaques were the main cause of Alzheimer's, leading to drug development focused on targeting them. However, a recent EurekAlert! article suggests that other factors, such as brain inflammation and astrocyte activity, play a significant role in disease progression. Astrocytes are star-shaped cells in the brain that support neurons, and the researchers found that they act as key regulators in Alzheimer's progression.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report